Fiduciary Trust Co. cut its holdings in shares of Aetna Inc (NYSE:AET) by 2.2% during the second quarter, HoldingsChannel reports. The institutional investor owned 12,349 shares of the company’s stock after selling 280 shares during the period. Fiduciary Trust Co.’s holdings in Aetna were worth $2,266,000 as of its most recent SEC filing.
A number of other institutional investors have also added to or reduced their stakes in AET. Diamond Hill Capital Management Inc. lifted its holdings in Aetna by 5.1% during the 1st quarter. Diamond Hill Capital Management Inc. now owns 1,715,322 shares of the company’s stock worth $289,890,000 after buying an additional 82,492 shares in the last quarter. Wells Fargo & Company MN lifted its holdings in Aetna by 101.0% during the 1st quarter. Wells Fargo & Company MN now owns 2,797,748 shares of the company’s stock worth $472,819,000 after buying an additional 1,405,859 shares in the last quarter. Daiwa Securities Group Inc. lifted its holdings in Aetna by 6.5% during the 1st quarter. Daiwa Securities Group Inc. now owns 12,212 shares of the company’s stock worth $2,064,000 after buying an additional 744 shares in the last quarter. Inverness Counsel LLC NY acquired a new stake in Aetna during the 1st quarter worth approximately $3,393,000. Finally, Dean Capital Investments Management LLC acquired a new stake in Aetna during the 1st quarter worth approximately $1,190,000. Institutional investors own 85.40% of the company’s stock.
A number of equities research analysts have issued reports on the stock. Zacks Investment Research upgraded shares of Aetna from a “sell” rating to a “hold” rating in a report on Monday. Cantor Fitzgerald reiterated a “buy” rating and set a $202.00 target price on shares of Aetna in a report on Thursday, August 2nd. ValuEngine upgraded shares of Aetna from a “hold” rating to a “buy” rating in a report on Tuesday, June 26th. Finally, Credit Suisse Group reduced their target price on shares of Aetna from $208.00 to $194.00 and set a “neutral” rating on the stock in a report on Monday, May 14th. Seven equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. The company has a consensus rating of “Buy” and a consensus target price of $200.38.
Shares of AET opened at $193.78 on Friday. Aetna Inc has a twelve month low of $149.69 and a twelve month high of $194.88. The firm has a market capitalization of $61.61 billion, a PE ratio of 18.24, a PEG ratio of 1.59 and a beta of 0.67. The company has a current ratio of 0.74, a quick ratio of 0.74 and a debt-to-equity ratio of 0.44.
Aetna (NYSE:AET) last announced its quarterly earnings data on Thursday, August 2nd. The company reported $3.43 earnings per share for the quarter, beating the Zacks’ consensus estimate of $3.04 by $0.39. Aetna had a net margin of 5.77% and a return on equity of 20.66%. The business had revenue of $15.56 billion for the quarter, compared to analyst estimates of $15.59 billion. During the same period last year, the business earned $3.42 EPS. The company’s revenue was up .2% on a year-over-year basis. equities analysts expect that Aetna Inc will post 11.28 EPS for the current year.
The company also recently disclosed a quarterly dividend, which was paid on Wednesday, August 1st. Stockholders of record on Wednesday, July 25th were issued a $0.50 dividend. The ex-dividend date was Tuesday, July 24th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.03%. Aetna’s payout ratio is 20.28%.
Aetna Inc operates as a health care benefits company in the United States. It operates through three segments: Health Care, Group Insurance, and Large Case Pensions. The Health Care segment offers medical, pharmacy benefit management service, dental, behavioral health, and vision plans on an insured and employer-funded basis.
Featured Story: Price to Earnings Ratio (PE), For Valuing Stocks
Want to see what other hedge funds are holding AET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aetna Inc (NYSE:AET).
Receive News & Ratings for Aetna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna and related companies with MarketBeat.com's FREE daily email newsletter.